Therapeutics , Targets , and Chemical Biology Combination of Antibody That Inhibits Ligand-Independent HER 3 Dimerization and a p 110 a Inhibitor Potently Blocks PI 3 K Signaling and Growth of HER 2 þ Breast Cancers